Yaoyao Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yaoyao Zhang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Fu-Hai Ji
Department of Anesthesiology, The First Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication Hao Tang
The Affiliated Hospital of Xuzhou Medical University Department of Pain, Xuzhou 221000, Jiangsu, China
1 shared publicationKai Sun
The Affiliated Hospital of Xuzhou Medical University Department of Pain, Xuzhou 221000, Jiangsu, China
1 shared publication- Li-Ping Chen
Department of Pain, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
1 shared publication Ting Wang
The Second Affiliated Hospital of Xuzhou Medical University Department of Pain, Xuzhou 221002, Jiangsu, China
1 shared publication- Wen Shen
The Affiliated Hospital of Xuzhou Medical University Department of Pain, Xuzhou 221000, Jiangsu, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2022 (1) , 1579937
Efficacy and Safety of Botulinum Toxin A and Pulsed Radiofrequency on Postherpetic Neuralgia: A Randomized Clinical Trial
This study evaluated the effectiveness and safety of botulinum toxin type A (BoNT‐A) and pulsed radiofrequency (RF) in the clinical treatment of postherpetic neuralgia (PHN). A total of 100 patients with PHN were randomly divided into two groups (n = 50 per group): RF group and BoNT‐A group. Based on conventional drug treatment, patients were treated with either a single nerve root pulsed radiofrequency therapy or a single local subcutaneous injection of BoNT‐A in the lesion area. All the patients were followed up for 24 weeks on pain scores, sleep quality, anxiety, and depression scores, etc. In the last follow‐up at the end of 24 weeks postoperation, the pain scores of patients in both groups were significantly lower than those before the operation (P < 0.05), indicating that both treatments were effective against PHN; however, there was no significant difference between these two groups (P > 0.05). It is noteworthy that the subcutaneous injection of BoNT‐A is relatively easy to administer and less expensive compared to RF. Therefore, we believe that the subcutaneous injection of BoNT‐A is an effective and safe method for the treatment of PHN.
- 1 January 2022
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2022 (1) , 1579937
Open AccessEfficacy and Safety of Botulinum Toxin A and Pulsed Radiofrequency on Postherpetic Neuralgia: A Randomized Clinical Trial
This study evaluated the effectiveness and safety of botulinum toxin type A (BoNT‐A) and pulsed radiofrequency (RF) in the clinical treatment of postherpetic neuralgia (PHN). A total of 100 patients with PHN were randomly divided into two groups (n = 50 per group): RF group and BoNT‐A group. Based on conventional drug treatment, patients were treated with either a single nerve root pulsed radiofrequency therapy or a single local subcutaneous injection of BoNT‐A in the lesion area. All the patients were followed up for 24 weeks on pain scores, sleep quality, anxiety, and depression scores, etc. In the last follow‐up at the end of 24 weeks postoperation, the pain scores of patients in both groups were significantly lower than those before the operation (P < 0.05), indicating that both treatments were effective against PHN; however, there was no significant difference between these two groups (P > 0.05). It is noteworthy that the subcutaneous injection of BoNT‐A is relatively easy to administer and less expensive compared to RF. Therefore, we believe that the subcutaneous injection of BoNT‐A is an effective and safe method for the treatment of PHN.